Fundz

Urigen Pharmaceuticals, Inc. reported raising $3.02 Million in an initial SEC Form D filing, from an offering of $3.02 Million

PRIVATENov 20, 2020

Amount Raised

$3.02 Million

$3.02 Million sold, per SEC Form D (first sale Nov 20, 2020)

Round Type

Seed

New BrunswickHealthcare

Quick answer

Vaneltix Pharma raised $3.02 Million in a Seed round, dated November 20, 2020. Vaneltix Pharma is based in New Brunswick, New Jersey, United States.

How much did Vaneltix Pharma raise?
Vaneltix Pharma raised $3.02 Million in a Seed round on November 20, 2020.
What does Vaneltix Pharma do?
Pain, urgency, frequency.
Where is Vaneltix Pharma based and how big is it?
Vaneltix Pharma is based in New Brunswick, New Jersey, United States.
Who are the decision-makers at Vaneltix Pharma?
Fundz holds 1 contact at Vaneltix Pharma. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Healthcare around the same time

Companies in the same sectors as Vaneltix Pharma that raised within 45 days of this round, from Fundz verified event records.

  • Poppins Health raised $1.4M (Seed) on January 4, 2021.
  • Hemispherian AS raised $58K (Pre-Seed) on January 4, 2021.
  • Kiora Pharmaceuticals raised $3.2M (Seed) on January 4, 2021.
  • Protean Biodiagnostics Inc. raised an undisclosed amount on January 4, 2021.
  • eMindful Inc. raised $500K (Seed) on January 4, 2021.
  • Medmo raised $3M on January 4, 2021.

Who to call at Vaneltix Pharma, and when

A new round usually means Vaneltix Pharma is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Vaneltix Pharma raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Vaneltix Pharma, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Vaneltix Pharma. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Vaneltix Pharma

Location

317 GEORGE STREET

New Brunswick, New Jersey, United States

About

Pain, urgency, frequency. Every day, urologic disorders continue to affect the lives of people all around us. Vaneltix is focused on providing immediate relief for patients suffering from Interstitial Cystitis / Bladder Pain Syndrome (IC/BPS), a disease of the lower urinary tract that predominantly affects women. For many, the path to a brighter more comfortable future, is Vaneltix.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Vaneltix Pharma raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contacts12 people are listed at Vaneltix Pharma. We don't have their email yet.See plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Vaneltix Pharma's next move

See what Strategic adds

Vaneltix Pharma raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.